Cord Blood Registry Launches Industry-Leading Innovations for Newborn Stem Cell Collection
New Collection System Offers Parents Opportunity to Preserve a Greater Number and Diversity of Their Newborn’s Umbilical Cord Stem Cells for More Potential Therapeutic Uses
Cord Blood Registry (CBR), the global leader in the collection and preservation of newborn stem cells from the umbilical cord, announced today the launch of its new stem cell collection system that saves a greater number and diversity of a newborn’s stem cells – from both the blood in the umbilical cord and the cord tissue itself – for a wider range of potential therapeutic uses.
Click link above for complete article.